Korro Bio, Inc.
KRRO
$12.35
-$0.11-0.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.58% | 16.62% | -13.56% | -23.67% | 0.24% |
| Total Depreciation and Amortization | 68.73% | 27.21% | -5.88% | -21.37% | -10.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.65% | -49.56% | -24.56% | 49.49% | 190.04% |
| Change in Net Operating Assets | 24.55% | 1,283.29% | -32.33% | 520.75% | -219.30% |
| Cash from Operations | -11.70% | 64.49% | -36.72% | 0.83% | -11.18% |
| Capital Expenditure | 97.88% | 12.27% | -1,882.93% | -34.80% | -270.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -870.00% | -9,743.20% | -- |
| Cash from Investing | 684.23% | -67.07% | -1,768.17% | -2,892.20% | -136.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.74% | -99.40% | 237.04% | 82,285.37% | 172.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.74% | -99.36% | 133.21% | 187,755.56% | -99.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.07% | -107.66% | -111.54% | -172.00% | -166.42% |